Cargando…
Long noncoding RNA H19 suppresses cardiac hypertrophy through the MicroRNA-145-3p/SMAD4 axis
Sustained cardiac hypertrophy (CH) contributes to many heart diseases. Long noncoding RNAs (lncRNAs) collectively play critical roles in cardiovascular diseases (CVDs). However, the roles of lncRNA H19 in CH are still unclear. A CH model was constructed utilizing isoproterenol (ISO). We demonstrated...
Autores principales: | Wang, Hao, Lian, Xiaoqing, Gao, Wei, Gu, Jie, Shi, Haojie, Ma, Yao, Li, Yafei, Fan, Yi, Wang, Qiming, Wang, Liansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973863/ https://www.ncbi.nlm.nih.gov/pubmed/35139769 http://dx.doi.org/10.1080/21655979.2021.2017564 |
Ejemplares similares
-
Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma
por: Wang, Ji Yu, et al.
Publicado: (2017) -
MicroRNA-143/-145 in Cardiovascular Diseases
por: Zhao, Wang, et al.
Publicado: (2015) -
MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3
por: Liu, Chi-Hsiu, et al.
Publicado: (2019) -
MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
por: Fernández-Villabrille, Sara, et al.
Publicado: (2023) -
Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics
por: Knoka, Evija, et al.
Publicado: (2020)